Answers are grounded in this paper and cite their sources.
Since the discovery of the inflammasome, interleukin 1 production has been found to be integral in the pathophysiology of gout. Interleukin 1 inhibition by Anakinra has been shown to effective for the treatment of gout. We report three cases of resistant chronic tophaceous gout who responded to anakinra subcutaneous injections on an intermittent basis.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: